Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Eiger BioPharmaceuticals, Inc. (EIGR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/06/2023 |
4
| Apelian David (CEO) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 750,000 options to buy
@ $0.729, valued at
$546.8k
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2023 |
4
| Sachdev Amit (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $1.705, valued at
$47.7k
|
|
| 03/03/2023 |
4
| Loh Evan (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $1.705, valued at
$47.7k
|
|
| 03/03/2023 |
4
| Murray Christine (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $1.705, valued at
$47.7k
|
|
| 03/03/2023 |
4
| Glenn Jeffrey S (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $1.705, valued at
$47.7k
|
|
| 03/03/2023 |
4
| Sablich Kim (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $1.705, valued at
$47.7k
|
|
| 03/03/2023 |
4
| Kelly-Croswell Lisa (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 28,000 options to buy
@ $1.705, valued at
$47.7k
|
|
| 03/03/2023 |
4
| Mayer Eldon C. III (Ex VP & Chief Commerc. Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 98,000 options to buy
@ $1.705, valued at
$167.1k
|
|
| 03/03/2023 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.705, valued at
$68.2k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| Mayer Eldon C. III (Ex VP & Chief Commerc. Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 31,500 options to buy
@ $1.37, valued at
$43.2k
|
|
| 01/30/2023 |
4
| Atkisson Erik (GC & Chief Compliance Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 26,750 options to buy
@ $1.37, valued at
$36.6k
|
|
| 01/25/2023 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 50,000 shares
@ $1.4316, valued at
$71.6k
|
|
| 01/03/2023 |
4
| Murray Christine (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $1.2208, valued at
$6.1k
|
|
| 12/27/2022 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Sold 22,500 shares
@ $1.169, valued at
$26.3k
|
|
| 12/27/2022 |
4
| Glenn Jeffrey S (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 100,000 shares
@ $1.2795, valued at
$128k
|
|
| 08/18/2022 |
4
| Apelian David (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Sold 5,000 shares
@ $9.8061, valued at
$49k
|
|
| 07/19/2022 |
4
| Kelly-Croswell Lisa (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $8.13, valued at
$243.9k
|
|
| 03/14/2022 |
4
| Ryali Sriram (CFO) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Sold 2,266 shares
@ $5.5973, valued at
$12.7k
|
|
| 03/14/2022 |
4
| Mayer Eldon C. III (Ex VP & Chief Commerc. Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Sold 1,657 shares
@ $5.5973, valued at
$9.3k
|
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Sablich Kim (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 12,000 options to buy
@ $5.1, valued at
$61.2k
|
|
| 03/11/2022 |
4
| Ryali Sriram (CFO) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 24,000 shares
@ $0
Granted 143,000 options to buy
@ $5.1, valued at
$729.3k
|
|
| 03/11/2022 |
4
| Murray Christine (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 12,000 options to buy
@ $5.1, valued at
$61.2k
|
|
| 03/11/2022 |
4
| Mayer Eldon C. III (Ex VP & Chief Commerc. Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 16,000 shares
@ $0
Granted 98,000 options to buy
@ $5.1, valued at
$499.8k
|
|
| 03/11/2022 |
4
| Glenn Jeffrey S (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 12,000 options to buy
@ $5.1, valued at
$61.2k
|
|
| 03/11/2022 |
4
| Loh Evan (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 12,000 options to buy
@ $5.1, valued at
$61.2k
|
|
| 03/11/2022 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 24,000 options to buy
@ $5.1, valued at
$122.4k
|
|
| 03/11/2022 |
4
| Cory David A (President and CEO) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 47,000 shares
@ $0
Granted 281,000 options to buy
@ $5.1, valued at
$1.4M
|
|
| 03/11/2022 |
4
| Atkisson Erik (GC & Chief Compliance Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 38,000 options to buy
@ $5.1, valued at
$193.8k
|
|
| 03/11/2022 |
4
| Apelian David (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 12,000 options to buy
@ $5.1, valued at
$61.2k
|
|
| 01/11/2022 |
4
| Mayer Eldon C. III (Ex VP & Chief Commerc. Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Sold 1,560 shares
@ $4.9501, valued at
$7.7k
|
|
|
|
|